GlycoNet is advancing research, innovation, and training in glycomics to improve the quality of life of Canadians.

GlycoNet is a one-stop global destination focused on developing new carbohydrate-based drugs, vaccines and diagnostics, in collaboration with academic and industry organizations to address areas of unmet need through applied glycomics research. This national platform supports translational research, protection of intellectual property, novel drug development, company formation and training of a new generation of glyco-scientists and entrepreneurs. The network includes over 170 researchers across Canada who focus on cancer, chronic diseases, infectious diseases, and neurodegenerative diseases.

GlycoNet is funded by the Government of Canada through the Networks of Centres of Excellence (NCE) Program.

GlycoNet “punches above its weight” in glycomics innovation.
(Institute of Health Economics Report, 2021)

0
Network Investigators
0
Trained HQP
0
Funded Projects
0
Network Partners

Latest News

Op-ed: Glycomics research supports a cure for Type 2 diabetes from plants

GlycoNet scientists at UBC have found a plant compound that helps control blood sugar levels in people with Type 2 diabetes.

Dr. Mariela Segura
Carbohydrate research in animal health supports Canadian economy

GlycoNet scientist Mariela Segura is developing glycomics-based solutions to improve livestock health.

GlycoNet start-up GlyCa Biosciences Inc. and Huron Innovation Inc. partner to improve prostate cancer detection

This partnership will launch the clinical trial of a new blood test to perfect early detection and diagnosis of clinically significant prostate cancer.

Network Members

Canadian Glycomics Network
E5-33 Gunning/Lemieux Chemistry Centre
University of Alberta, T6G 2G2
Tel: 780-492-6204
Fax: 780-492-4147

Subscribe to GlycoNet’s Newsletter

© CANADIAN GLYCOMICS NETWORK (GLYCONET). ALL RIGHTS RESERVED.

en_USEnglish
Scroll to Top